home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Lightning Strikes Twice For Milk Drinkers

 
  December, 21 2006 1:49
your information resource in human molecular genetics
 
     
The ability of Africans and Europeans to digest milk as adults is a textbook example of a trait arising independently in two populations in response to the same strong selective pressure. This ability -- known as lactase persistence -- is analyzed in the January 2007 issue of Nature Genetics.

Lactase persistence is frequent in Northern European populations, but much lower elsewhere, and may have become established as a consequence of cattle domestication and a pastoralist lifestyle. Previous work had shown that genetically, it could be attributed to variants that control the expression of the gene encoding the enzyme lactase-phlorizin hydrolase (LPH). This enzyme breaks down lactose into more easily absorbed sugars such as glucose and galactose.

Sarah Tishkoff and colleagues asked whether the genetic basis of lactase persistence in certain pastoralist populations in East Africa might be attributed to the same variants. They studied 470 lactase-persistent and lactase non-persistent individuals from Kenya, Tanzania, and Sudan and found a significant association between lactase persistence and one variant that is very close in location to the LPH variant previously associated with the trait in Europeans. Because other genetic markers in the region differed between the two populations, the authors conclude that the lactase persistent-associated LPH variants arose independently..

Author contact:

Sarah Tishkoff (University of Maryland, College Park, MD, USA)
E-mail: tishkoff@umd.edu

Abstract available online.

(C) Nature Genetics press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.